Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Liabilities: 2011-2024

Historic Total Liabilities for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $124.1 million.

  • Veracyte's Total Liabilities rose 11.26% to $110.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 11.26%. This contributed to the annual value of $124.1 million for FY2024, which is 75.23% up from last year.
  • According to the latest figures from FY2024, Veracyte's Total Liabilities is $124.1 million, which was up 75.23% from $70.8 million recorded in FY2023.
  • In the past 5 years, Veracyte's Total Liabilities ranged from a high of $124.1 million in FY2024 and a low of $35.9 million during FY2020.
  • Moreover, its 3-year median value for Total Liabilities was $81.2 million (2022), whereas its average is $92.0 million.
  • In the last 5 years, Veracyte's Total Liabilities surged by 154.13% in 2021 and then declined by 12.83% in 2023.
  • Over the past 5 years, Veracyte's Total Liabilities (Yearly) stood at $35.9 million in 2020, then spiked by 154.13% to $91.3 million in 2021, then declined by 11.05% to $81.2 million in 2022, then decreased by 12.83% to $70.8 million in 2023, then skyrocketed by 75.23% to $124.1 million in 2024.